If you said diabetes, you're right -- a new study finds diabetes costs $101 billion annually in diagnosis and treatment and ...

Inspired by the way that squids use jets to propel themselves through the ocean and shoot ink clouds, researchers from MIT ...

Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...

Readouts from Novo Nordisk and Viking Therapeutics at AASLD 2024 strengthen the argument for GLP-1 therapies as an emerging ...

The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...

GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions ...

NEW YORK (Reuters) - About 44% of U.S. employers with 500 or more employees cover drugs for weight loss in 2024, up from 41% ...

Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.

Old Town Med Spa is among those being accused of using false advertising and deceptive marketing practices to sell ...

European mega-caps trail US 'Magnificent Seven' amid lack of artificial intelligence gains, while also facing China's ...

A groundbreaking Harvard study reveals that semaglutide could benefit more people in the U.S. than ever imagined.